Isolation and antimalarial activity of peroxydisulfate oxidation products of primaquine

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 24, 2002, Pages 3587-3589

  Dua, Virendra K ^a   Sinha, Sukesh N ^a   Biswas, Sukla ^a   Valecha, N ^a   Puri, S K ^b   Sharma, V P ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5,5 BIS[6 METHOXY 8 (4' AMINO 1' METHYLBUTYLAMINO)QUINOLINE]; 5,5 BIS[7 HYDROXY 6 METHOXY 8 (4' AMINO 1' METHYLBUTYLAMINO)QUINOLINE]; 6 METHOXY 5,8 BIS(4' AMINO 1' METHYLBUTYLAMINO)QUINOLINE; 6,7 DIHYDROXY 5,8 BIS(4' AMINO 1' METHYLBUTYLAMINO)QUINOLINE; ANTIMALARIAL AGENT; N,N,N TRIS(1 AMINOPENTYL)AMINE; PRIMAQUINE DERIVATIVE; SULFATE; UNCLASSIFIED DRUG; PRIMAQUINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ISOLATION; GAMETOCYTE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATION; PLASMODIUM YOELII; ANIMAL; CHEMISTRY; DRUG EFFECT; GERM CELL; ISOLATION AND PURIFICATION; MALARIA; MICROBIOLOGY; MOSQUITO; OOCYST; OXIDATION REDUCTION REACTION;

PLASMODIUM YOELII;

ANIMALS; ANTIMALARIALS; CULICIDAE; GERM CELLS; MALARIA; MICE; OOCYSTS; OXIDATION-REDUCTION; PLASMODIUM YOELII; PRIMAQUINE; SULFATES;

EID: 0036889627     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00802-8     Document Type: Article

References (13)

1. Carson, P. E. In Antimalarial Drugs II ; Peters, W.; Richards, W. H. G., Ed; Springer-Verlag: New York, 1984; pp 83-121.
2. Beutler E., Dern R.J., Alving A.S. J. Lab. Clin. Med. 44:1954;177.
3. Milhous W.K., Robinson B.L., Breuckner R.P., Schuster B.G., Peters W. Am. J. Trop. Med. Hyg. 47(Suppl.):1992;89.
4. Jain R., Gupta R.C., Anand N. Ind. J. Chem. 33:1994;792.
5. Lamontagne M.P., Blumbergs P., Strube R.E. J. Med. Chem. 25:1982;1094.
6. Lamontagne M.P., Markovac A., Khan M.S. J. Med. Chem. 25:1982;964.
7. Brossi A., Gessner W., Hufford C.D., Baker J.K., Homo F., Millet P., Landau I. FEBS Lett. 223:1987;77.
8. Dua V.K., Sinha S., Sharma V.P. J. Chromatog. 708:1998;316.
9. 5 and primaqine were 9.0, 4.6, 3.0, 5.4, 4.0 and 10.0 min respectively. Small scale preparative chromatography was carried out with a combination of Bio-Gel column chromatography and reverse phase HPLC.
10. -1 (Intraperitoneal) and mosquito feeding was repeated at -1, 6 and 24 h. after injection. The fed mosquitoes were kept at 24±2°C and 70±5% relative humidity in the insectory. Mosquito dissection were done on the 4th day and average oocyst were calculated to find infectivity. Activity is assessed by comparing the number of oocytes on the midgets of mosquitoes fed on drug treated mice with those of the insects fed on untreated animals. A group of infected mice without being administered any drug was kept an untreated control.
11. Clark A.M., Hufford C.D., McChesney J.D. Antimicrob. Agents Chemother. 19:1981;337.
12. Clark A.M., Hufford C.D., Puri R.K., McChesney J.D. Appl. Environ. Microbiol. 47:1984;540.
13. Bhasin, V. K.; Trager, W. In Primaquine; Pharmacokinetics, Metabolism, Toxicity and Activity; Wernsdorfer, W. H. Trigg, P.I., Ed.; John Wiley & Sons, 1984; pp 145-153.